학술논문
Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders
Document Type
Short Communication
Source
In Blood Advances 25 July 2023 7(14):3431-3434
Subject
Language
ISSN
2473-9529